Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Prepaid Assets (2023 - 2025)

Historic Prepaid Assets for Contineum Therapeutics (CTNM) over the last 3 years, with Q3 2025 value amounting to $2.5 million.

  • Contineum Therapeutics' Prepaid Assets rose 10454.55% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year increase of 10454.55%. This contributed to the annual value of $1.6 million for FY2024, which is 3529.41% down from last year.
  • Latest data reveals that Contineum Therapeutics reported Prepaid Assets of $2.5 million as of Q3 2025, which was up 10454.55% from $1.4 million recorded in Q2 2025.
  • Over the past 5 years, Contineum Therapeutics' Prepaid Assets peaked at $2.5 million during Q3 2025, and registered a low of $1.2 million during Q3 2024.
  • Over the past 3 years, Contineum Therapeutics' median Prepaid Assets value was $1.6 million (recorded in 2024), while the average stood at $1.8 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first tumbled by 3529.41% in 2024, then surged by 10454.55% in 2025.
  • Contineum Therapeutics' Prepaid Assets (Quarter) stood at $2.5 million in 2023, then plummeted by 35.29% to $1.6 million in 2024, then skyrocketed by 54.79% to $2.5 million in 2025.
  • Its last three reported values are $2.5 million in Q3 2025, $1.4 million for Q2 2025, and $1.4 million during Q1 2025.